Prosecution Insights
Last updated: October 02, 2026
Application No. 19/039,165

APPARATUS AND METHODS FOR RECEIVING DISCHARGED URINE

Non-Final OA §101
Filed
Jan 28, 2025
Priority
Mar 19, 2014 — provisional 61/955,537 +13 more
Examiner
MENSH, ANDREW J
Art Unit
Tech Center
Assignee
PureWick Corporation
OA Round
1 (Non-Final)
64%
Grant Probability
Moderate
1-2
OA Rounds
1y 10m
Est. Remaining
84%
With Interview

Examiner Intelligence

Grants 64% of resolved cases
64%
Career Allowance Rate
385 granted / 599 resolved
+4.3% vs TC avg
Strong +19% interview lift
Without
With
+19.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
30 currently pending
Career history
631
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
60.1%
+20.1% vs TC avg
§102
13.6%
-26.4% vs TC avg
§112
16.4%
-23.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 599 resolved cases

Office Action

§101
DETAILED ACTION Note: The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of Claims 1. Claims 1 is pending and currently under consideration for patentability. Priority 2. Applicant’s claim for the benefit of a prior-filed application under 35 U.S.C. 119(e) or under 35 U.S.C. 120, 121, or 365(c) is acknowledged. Information Disclosure Statement 3. The information disclosure statements (IDS) submitted on January 28, 2025 is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement has been considered by the examiner. Statutory Double Patenting 4. A rejection based on double patenting of the “same invention” type finds its support in the language of 35 U.S.C. 101 which states that “whoever invents or discovers any new and useful process... may obtain a patent therefor...” (Emphasis added). Thus, the term “same invention,” in this context, means an invention drawn to identical subject matter. See Miller v. Eagle Mfg. Co., 151 U.S. 186 (1894); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Ockert, 245 F.2d 467, 114 USPQ 330 (CCPA 1957). A statutory type (35 U.S.C. 101) double patenting rejection can be overcome by canceling or amending the claims that are directed to the same invention so they are no longer coextensive in scope. The filing of a terminal disclaimer cannot overcome a double patenting rejection based upon 35 U.S.C. 101. 5. Claim 1 is/are rejected under 35 U.S.C. 101 as claiming the same invention as that of claim 1 of prior U.S. Patent No.12,239,567. This is a statutory double patenting rejection. With regard to claim 1, Patent ‘567 discloses “A fluid collection device, comprising: a fluid impermeable layer having a proximal end region and a distal end region, the fluid impermeable layer at least partially defining an interior volume of the fluid collection device and at least partially forming a first region of the fluid collection device; a fluid permeable membrane having an outer surface positioned to contact skin of a user and form at least a portion of a second region of the fluid collection device, wherein the outer surface of the fluid permeable membrane extends convexly outward away from at least a portion of the fluid impermeable layer; an outlet positioned at the proximal end region of the fluid impermeable layer and in fluid communication with the interior volume of the fluid collection device; a sump positioned in the distal end region of the fluid impermeable layer, the sump being defined at least partially by the fluid impermeable layer; an elongated tube having an intake end disposed in the interior volume at least proximate to the sump and in fluid communication with the outlet; a permeable member disposed at least partially in the interior volume of the fluid collection device, wherein the permeable member and the fluid permeable membrane are at least partially concentric around the elongated tube (See claim 1 of Patent ‘567).” Conclusion 6. The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: Sanchez (US 8,287,508) discloses a fluid collection device (60; abstract; Figs. 3, 8), comprising: a fluid impermeable layer/backing (closed container, 62) having a proximal end region (“one end” having outlet port, 68) and a distal end region (opposite end, 72), the fluid impermeable layer/backing (62) at least partially defining an interior volume (internal chamber, 64) of the fluid collection device (60) and at least partially forming a first region (region opposite to array of openings, 66) of the fluid collection device (60; Fig. 8; col. 6, lines 12-31); a fluid permeable membrane (moisture wicking material, 20; best seen in Figs. 2, 3, 4) having an outer surface positioned to contact skin of a user and form at least a portion of a second region (region having openings, 66) of the fluid collection device (60), wherein the outer surface of the fluid permeable membrane (20) extends convexly outward away (see Figs. 2, 3, 4; where 20 extends convexly outward away by virtue of its wrapping around 62) from at least a portion of the fluid impermeable layer/backing (62; col. 6, lines 32-40); an outlet (68) positioned at the proximal end region of the fluid impermeable layer/backing (62) and in fluid communication with the interior volume (64) of the fluid collection device (62; col. 6, lines 32-40; Figs. 2, 3); a sump (lowest portion within the chamber; col. 6, lines 12-31; “the opposite end 72 of the container 62 can be positioned conveniently at a lower elevation than the remainder of the container so that the urine-transfer tube 70 is positioned for receiving the voided urine that collects in the lowest portion within the chamber 64”) positioned in the distal end region (72) of the fluid impermeable layer/backing (62) distal to the outlet (68; Fig. 8), the sump (lowest portion within the chamber) being defined at least partially by the fluid impermeable layer/backing (62; Fig. 8); and an elongated tube (urine transfer tube, 70) having an intake end disposed in the interior volume (64) at least proximate to the sump (lowest portion within the chamber) and in fluid communication with the outlet (68; Fig. 8). Wolff et al. (US 6,740,066) discloses a urine collection device (abstract; Figs. 5a-5b), comprising a fluid impermeable layer (outer layer, 33), a moisture-wicking layer (nylon mesh layer, 38), and an outlet (35) connected to an elongated tube (col. 5, line 56 - col. 6, line 23); wherein an elongated member (open-structured shape-retaining material, 39) is provided and configured to retain a nonlinear configuration after being adjusted to the nonlinear configuration to maintain the fluid collection device in the nonlinear configuration (col. 6, lines 24-35); wherein the elongated member (39) is proximate to the elongated tube (35; see Figs. 5a-5b). Martin (US 4,631,061) discloses a substantially cylindrical fluid collection device (collection vessel, 22; abstract; Figs. 1, 8), comprising: a fluid impermeable backing/layer (“formed of a liquid impermeable material”; col. 3, lines 15-21) at least partially defining an interior volume of the fluid collection device (22) and at least partially forming a first region (region having deep well, 92) and a second region (opposite top region); and an outlet (through flexible tube, 24) in fluid communication with the interior volume (well 92) of the fluid collection device (22; col. 2, line 65 - col. 3, line 37); wherein the fluid impermeable layer (22) defines one or more vacuum relief openings (air vents, 91; Fig. 8; col. 3, lines 34-37). Tanimoto et al. (US 9,173,799) discloses a urine disposal device (11; abstract; Figs. 1, 5, 9, 11). Lawrence et al. (US 5,678,564) discloses a liquid removal system (abstract; Figs. 1-4). 7. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ANDREW J MENSH whose telephone number is (571)270-1594. The examiner can normally be reached M-F 9 a.m. - 6 p.m.. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sarah Al-Hashimi can be reached at (571)272-7159. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ANDREW J MENSH/ Primary Examiner, Art Unit 3781
Read full office action

Prosecution Timeline

Jan 28, 2025
Application Filed
Sep 10, 2026
Non-Final Rejection mailed — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12745935
SURGICAL SUCTION DEVICE THAT USES POSITIVE PRESSURE GAS
5y 8m to grant Granted Sep 29, 2026
Patent 12746145
HUMAN INTERFACE DEVICE FOR URINARY RELIEF SYSTEM
3y 6m to grant Granted Sep 29, 2026
Patent 12745951
ELECTROSTATIC DISCHARGE PROTECTION FOR SENSORS IN WOUND THERAPY
2y 6m to grant Granted Sep 29, 2026
Patent 12741075
Vacuum Chamber with Snap Fit Plunger Mechanism
4y 6m to grant Granted Sep 22, 2026
Patent 12702765
MULTISTAGE VAPORIZER FOR MEDICAL TREATMENT SYSTEM
3y 0m to grant Granted Aug 11, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
64%
Grant Probability
84%
With Interview (+19.2%)
3y 6m (~1y 10m remaining)
Median Time to Grant
Low
PTA Risk
Based on 599 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month